Your browser doesn't support javascript.
loading
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.
Parry, H; McIlroy, G; Bruton, R; Ali, M; Stephens, C; Damery, S; Otter, A; McSkeane, T; Rolfe, H; Faustini, S; Wall, N; Hillmen, P; Pratt, G; Paneesha, S; Zuo, J; Richter, A; Moss, P.
Afiliación
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • McIlroy G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Ali M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Damery S; Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Otter A; National infection Service, Public Health England, Porton Down, Salisbury, SP4 OJG, UK.
  • McSkeane T; Cancer Research UK Clinical Trials Unit, University of Birmingham, B15 2TT, Birmingham, UK.
  • Rolfe H; Cancer Research UK Clinical Trials Unit, University of Birmingham, B15 2TT, Birmingham, UK.
  • Faustini S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Wall N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Hillmen P; St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
  • Pratt G; Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, B15 2TH, UK.
  • Paneesha S; Birmingham Heartlands Hospital, University Hospitals Birmingham, Bordesley Green East, B9 5SS, Birmingham, UK.
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Richter A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK. P.moss@bham.ac.uk.
Blood Cancer J ; 11(7): 136, 2021 07 30.
Article en En | MEDLINE | ID: mdl-34330895
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Inmunización Secundaria / Vacunas contra la COVID-19 / COVID-19 / Anticuerpos Antivirales / Formación de Anticuerpos Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Inmunización Secundaria / Vacunas contra la COVID-19 / COVID-19 / Anticuerpos Antivirales / Formación de Anticuerpos Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido